Under Act 17, part 2 in executive order no. 226 dated March 15, 2007 on reporting obligations, BioPorto A/S hereby announces that the company's total share capital amounts to DKK 114,907,872 divided into shares of DKK 3.00 each, equivalent of 38,302,624 votes. BioPorto has ended the classification of A and B shares after which all shares belong to the same share class with the same rights. The 20,000 A-shares have thus been admitted to trading and official listing. New short name: BIOPOR For further information please contact: Christina Tønnesen, Investor Relations Tel. +45 45 29 00 34, e-mail info@bioporto.com
Attachments
Recommended Reading
-
June 15, 2026 Announcement no. 13 Grant of Warrants Copenhagen, Denmark, June 15, 2026, (GLOBE NEWSWIRE) – The Board of...
Read More -
June 9, 2026Announcement no. 12 BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback COPENHAGEN, DENMARK, June 9, 2026 – BioPorto A/S (“BioPorto”...
Read More